CLARITY MEDICAL (01406): Xu Yong resigns as Co-Chief Executive Officer
Clear Medical (01406) announced that Mr. Xu Yong (Mr. Xu) has resigned from the following positions in order to devote more time to other personal matters and business responsibilities: Co-Chief Executive Officer of the Company; and the Company's authorized representative in Hong Kong for receiving legal process documents and notices in accordance with Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong), with effect from April 30, 2026. After his resignation, Mr. Xu will continue to serve as a senior consultant of the Company until June 30, 2026.
CLARITY MEDICAL (01406) announced that Mr. Xu Yong (Mr. Xu) has resigned from the following positions in order to devote more time to handling other personal matters and business responsibilities: Co-Chief Executive Officer of the company; and the authorized representative of the company in Hong Kong for receiving legal process documents and notices as stipulated in Section 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong), effective from April 30, 2026. After his resignation, Mr. Xu will continue to serve as a senior advisor of the company until June 30, 2026.
Related Articles
In the first quarter, the net profit attributable to shareholders of SHANGHAI QINGPU (08115) was 7.266 million yuan, an increase of 627.3% year-on-year.
WASION HOLDINGS (03393) appoints Zhang Libin as an independent non-executive director.
PROSP INV HOLD (00310): The comprehensive asset net value per share at the end of April is approximately HK$0.028.
In the first quarter, the net profit attributable to shareholders of SHANGHAI QINGPU (08115) was 7.266 million yuan, an increase of 627.3% year-on-year.
WASION HOLDINGS (03393) appoints Zhang Libin as an independent non-executive director.
PROSP INV HOLD (00310): The comprehensive asset net value per share at the end of April is approximately HK$0.028.
